Zenas BioPharma (ZBIO) EPS (Weighted Average and Diluted) (2023 - 2026)
Zenas BioPharma (ZBIO) recorded quarterly EPS (Weighted Average and Diluted) of -$1.46 in Q1 2026, up 71.76% quarter-over-quarter from -$5.17 in Q4 2025, and down 82.5% on a YoY basis from -$8.34 in Q1 2025.
Zenas BioPharma (ZBIO) EPS (Weighted Average and Diluted) (2023 - 2026) Analysis & Trends
Zenas BioPharma's EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$1.46 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 82.5% year-over-year to -$1.46; the TTM figure through Mar 2026 stood at -$9.1 (up 30.59% YoY), while the FY2025 annual figure was -$8.44, up 29.02% from the prior year.
- EPS (Weighted Average and Diluted) was -$1.46 for Q1 2026 at Zenas BioPharma, up from -$5.17 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $16.94 in Q4 2024 to a low of -$24.23 in Q2 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$4.93 across 4 years, with a median of -$1.46 in 2026.
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 205.61% in 2024; the steepest drop was 356.12% in 2024.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$16.04 in 2023, then jumped by 205.61% to $16.94 in 2024, then plunged by 130.52% to -$5.17 in 2025, then soared by 71.76% to -$1.46 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.46 (Q1 2026), -$5.17 (Q4 2025), and -$1.22 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - | -1.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 |
| Dec 31, 2025 | -5.17 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -1.25 |
| Mar 31, 2025 | -0.80 |
| Dec 31, 2024 | 16.94 |
| Sep 30, 2024 | -5.02 |
| Jun 30, 2024 | -24.23 |
| Mar 31, 2024 | -17.89 |
| Dec 31, 2023 | -16.04 |
| Sep 30, 2023 | 1.96 |